TaiMed Biologics Inc. (4147.TWO)

TWD 82.5

(-0.48%)

Annual Balance Sheets

(In TWD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 3.89 Billion 4.1 Billion 4.61 Billion 5.19 Billion 4.73 Billion 4.79 Billion
Total Current Assets 2.15 Billion 2.16 Billion 2.33 Billion 2.77 Billion 2.45 Billion 2.51 Billion
Cash And Short Term Investments 649.13 Million 645.39 Million 960.88 Million 1.2 Billion 1.27 Billion 2.01 Billion
Cash and Cash Equivalents 251 Million 274.11 Million 551.61 Million 572.09 Million 352.93 Million 586.09 Million
Short Term Investments 398.12 Million 371.28 Million 409.26 Million 631.56 Million 921.54 Million 1.42 Billion
Net Receivables 161.86 Million 98.9 Million 170.96 Million 270.3 Million 222.01 Million 110.2 Million
Inventory 1.26 Billion 1.38 Billion 1.16 Billion 1.25 Billion 876.03 Million 380.55 Million
Other Current Assets 75.21 Million 38.51 Million 34.89 Million 44.43 Million 84.63 Million 16 Million
Total Non-Current Assets 1.74 Billion 1.93 Billion 2.27 Billion 2.41 Billion 2.27 Billion 2.27 Billion
Net PPE 908.25 Million 957.73 Million 1.01 Billion 1.06 Billion 940.31 Million 863.18 Million
Good Will And Intangible Assets 625.78 Million 724.37 Million 821.33 Million 940.15 Million 739.44 Million 642.28 Million
Good Will - - - - - -
Intangible Assets 625.78 Million 724.37 Million 821.33 Million 940.15 Million 739.44 Million 642.28 Million
Long-Term Investments -397.22 Million -327.84 Million -176.63 Million -428.57 Million -672.18 Million -963.38 Million
Tax Assets 599.6 Million - 611.99 Million 834.91 Million 1.12 Billion 1.63 Billion
Other Non Current Assets 6.1 Million 581.85 Million 8.46 Million 7.24 Million 140.49 Million 99.35 Million
Other Assets - - - - - -
Total Liabilities 1.32 Billion 1.38 Billion 1.66 Billion 1.78 Billion 1.14 Billion 710.55 Million
Total Current Liabilities 361.17 Million 329.86 Million 225.07 Million 461.52 Million 428.1 Million 235.93 Million
Account Payables 13.49 Million 89 Thousand 122.58 Million 6.16 Million 136.17 Million 149.86 Million
Tax Payables - - - - - -
Short Term Debt 229.14 Million 216.33 Million 1.94 Million 1.92 Million 1.84 Million -12.93 Million
Deferred Revenue 114.97 Million 57.48 Million 99.19 Million 430.33 Million 257.02 Million 12.93 Million
Other Current Liabilities 3.54 Million 55.95 Million 1.35 Million 23.1 Million 33.06 Million 86.07 Million
Total Non Current Liabilities 966.66 Million 1.05 Billion 1.44 Billion 1.31 Billion 716.25 Million 474.61 Million
Long-Term Debt 521.7 Million 549.8 Million 565.37 Million 567.32 Million 32.15 Million -
Deferred Revenue Non Current 444.03 Million 505.6 Million 877.9 Million 750.74 Million 683.24 Million 473.75 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 920 Thousand 920 Thousand 868 Thousand 858 Thousand 858 Thousand 858 Thousand
Other Liabilities - - - - - -
Total Equity 2.56 Billion 2.71 Billion 2.94 Billion 3.41 Billion 3.58 Billion 4.08 Billion
Stock Holders Equity 2.56 Billion 2.71 Billion 2.94 Billion 3.41 Billion 3.58 Billion 4.08 Billion
Common Stock 2.53 Billion 2.52 Billion 2.52 Billion 2.52 Billion 2.52 Billion 2.51 Billion
Retained Earnings -934.55 Million -740.22 Million -470.93 Million -3.92 Billion -3.73 Billion -3.15 Billion
Accumulated other comprehensive income 151.86 Million 149.66 Million 120.42 Million 130 Million 119.69 Million 111.87 Million
Common Stock Equity 2.56 Billion 2.71 Billion 2.94 Billion 3.41 Billion 3.58 Billion 4.08 Billion
Capital Lease Obligation 28.84 Million 30.14 Million 31.32 Million 33.25 Million 33.99 Million -
Total Investments 898 Thousand 43.43 Million 232.63 Million 202.99 Million 249.36 Million 462.53 Million
Total Debt 750.85 Million 766.14 Million 567.32 Million 569.25 Million 33.99 Million -
Net Debt 499.84 Million 492.03 Million 15.7 Million -2.83 Million -318.93 Million -586.09 Million

Balance Sheet Charts